The terminal steps of cortisol and aldosterone biosynthesis
皮质醇和醛固酮生物合成的最终步骤
基本信息
- 批准号:10252327
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Active SitesAdrenal CortexAdrenal GlandsAdverse effectsAffinityAgeAldosteroneAnabolismAndrogensBindingBiochemicalBiochemistryCYP11B2 geneCell LineCellsCessation of lifeChromosome 8ComplexConsumptionCorticosteroneCortodoxoneCouplingCytochrome P450DataDeoxycorticosteroneDiabetes MellitusDiseaseDissociationDrug DesignDrug TargetingDyslipidemiasEnvironmentEnzymesEquilibriumGenesGeometryGlucocorticoidsGlucose IntoleranceGoalsHeart failureHomeostasisHumanHydrocortisoneHydroxylationHypertensionHypotensionImpairmentIntrinsic factorKineticsLaboratoriesLeadLipidsMedicalMedical HistoryMembraneMembrane LipidsMetabolismMichiganMicroscopicMineralocorticoidsMitochondriaMixed Function OxygenasesMolecular ConformationMorbidity - disease rateMutagenesisMutationNADPNatureObesityOperative Surgical ProceduresOrganOxidasesOxidation-ReductionPathway interactionsPharmaceutical PreparationsPhysiologicalPoint MutationPositioning AttributeProductionPropertyReactionRegulationReproducibilityResearchSeriesSodium ChlorideSteroidsStressStructureSystemTestingTherapeuticTherapeutic IndexUniversitiesVeteransWaterWorkZona FasciculataZona GlomerulosaZona Reticularisbone masscarbohydrate metabolismchemical propertycomorbidityenzyme activityenzyme structureenzyme substrateexperimental studyhuman diseasehypertension treatmentin vivoinhibitor/antagonistinsightinstrumentationnanodisknoveloxidationphysical propertyreceptorresponseside effectsingle moleculesmall moleculesteroid hormonesurgical risktandem mass spectrometrytool
项目摘要
Excess aldosterone and cortisol production from the human adrenal cortex commonly contributes to
hypertension, heart failure, obesity, glucose intolerance, and low bone mass. Cytochromes P450 11B2 and
P450 11B1 catalyze the final steps in the biosynthesis of aldosterone and cortisol, respectively. The zone-
specific regulation of these enzymes maintains salt and water balance or carbohydrate metabolism and
response to physiologic stress. The enzymes share 95% sequence similarity, and both catalyze the 11β-
hydroxylation of 11-deoxycorticosterone and 11-deoxycortisol. In contrast, the 18-hydroxylase of P450 11B1 is
poor compared to P450 11B2, and only P450 11B2 has 18-oxidase activity, which converts 18-hydroxy-
corticosterone to aldosterone. P450 11B2 has high processivity, in that the intermediates predominantly do not
dissociate before additional turnovers to aldosterone, but the reasons for this processivity and whether this
property is required for aldosterone production are not known. A comparison of its microscopic steps with
those of P450 11B1 offers an opportunity to understand the unique biochemistry of aldosterone production.
Our long-term goal is to elucidate the biochemical and physical properties that confers high 18-
hydroxylase and moderate 18-oxidase activities to P450 11B2 but not P450 11B1. Our central hypotheses
are that: (1) the positioning of nascent corticosterone generated from 11-deoxycorticosterone in the active site
and the conformation of P450 11B2 is different that the nature of the complex when corticosterone binds as
initial substrate; and (2) that the processivity of P450 11B2 reflects a combination of slow dissociation rates
and high coupling efficiency with the intermediates. Consequently, the objectives of this application are to
characterize the binding constants, binding and dissociation rates, pre-steady state (single turnover) kinetics,
and coupling efficiencies for P450 11B1 and P450 11B2 with several substrates and to deduce which
parameters correlate best with processivity. As tools for these studies, we will employ mutations that alter the
activities for P450 11B1 and P450 11B2 and alternate substrates that have specific chemical properties.
In Aim 1, we will dissect the 18-hydroxylase activity of P450 11B1 and P450 11B2, wild-type and
mutations. In Aim 2, we will focus on the 18-oxidase activity with a parallel series of studies as in Aim 2. In Aim
3, we will focus on extrinsic factors, specifically the lipid composition of the membrane environment, in
regulating the processivity and latter two activities of P450 11B2. We will use nanodiscs to generate artificial
enzyme-membrane systems and confirm key results in transfected HEK-293 or V79 cells. The work will utilize
the specialized instrumentation that the Auchus and Waskell laboratories have employed to study cytochrome
P450 enzymes for many years and state-of-the art tandem mass spectrometry at the University of Michigan. In
this manner, we will systematically define the differences in the reaction mechanisms and properties for P450
11B1 and P450 11B2. These studies will inform strategies to screen for better drugs to safely inhibit key steps
of aldosterone and cortisol production for the treatment of human diseases.
人类肾上腺皮质产生过多的醛固酮和皮质醇通常会导致
高血压、心力衰竭、肥胖、糖耐量减低和骨量减少。细胞色素P450 11B2和
P450 11B1分别催化醛固酮和皮质醇生物合成的最后步骤。该地带-
这些酶的特定调节维持盐和水的平衡或碳水化合物代谢,并
对生理压力的反应。这两种酶具有95%的序列相似性,并且都催化11β-
11-脱氧皮质酮和11-脱氧皮质醇的羟基化。相比之下,P450 11B1的18-羟基酶是
与P450 11B2相比,P450 11B2的活性较差,并且只有P450 11B2具有18-氧化酶活性,它能将18-羟基-2
从皮质酮到醛固酮。P450 11B2具有很高的加工性,因为中间体主要不
在更多的转化为醛固酮之前解离,但这种过程的原因以及这是否
生产醛固酮所需的属性尚不清楚。它的微观步骤与
这些P450 11B1提供了一个机会,以了解独特的生物化学的醛固酮生产。
我们的长期目标是阐明导致高18岁的生化和物理特性-
羟基酶和中等活性的18-氧化酶对P450 11B2而不是P450 11B1。我们的中心假设
是:(1)11-脱氧皮质酮生成的新生皮质酮在活性部位的定位
P45011B2的构象不同于皮质酮与AS结合时复合体的性质
初始底物;以及(2)P450 11B2的加工性反映了慢解离速率的组合
与中间体的偶联效率高。因此,本应用程序的目标是
表征结合常数、结合和解离速率、稳态前(单周转)动力学、
以及P450 11B1和P450 11B2与几种底物的偶联效率,并推导出
参数与过程性的相关性最好。作为这些研究的工具,我们将使用改变
P450 11B1和P450 11B2以及具有特定化学性质的替代底物的活性。
在目标1中,我们将剖析野生型和野生型P450 11B1和P450 11B2的18-羟基酶活性
突变。在目标2中,我们将与目标2一样,通过一系列平行的研究集中于18-氧化酶的活性。
3、我们将重点关注外在因素,特别是膜环境的脂质成分,在
调节P450 11B2的加工性和后两种活性。我们将使用纳米盘来产生人造
并在HEK-293或V79细胞中证实了关键结果。这项工作将利用
Auchus和Waskell实验室用来研究细胞色素的专门仪器
多年的P450酶和密歇根大学最先进的串联质谱仪。在……里面
通过这种方式,我们将系统地定义P450的反应机理和性质的差异
11B1和P450 11B2。这些研究将为筛选安全抑制关键步骤的更好药物的策略提供依据
用于治疗人类疾病的醛固酮和皮质醇的生产。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD J. AUCHUS其他文献
RICHARD J. AUCHUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD J. AUCHUS', 18)}}的其他基金
The terminal steps of cortisol and aldosterone biosynthesis
皮质醇和醛固酮生物合成的最终步骤
- 批准号:
10664898 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The terminal steps of cortisol and aldosterone biosynthesis
皮质醇和醛固酮生物合成的最终步骤
- 批准号:
10409567 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Streamlined Diagnostic Strategy for Primary Aldosteronism
原发性醛固酮增多症的简化诊断策略
- 批准号:
9027843 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
细胞色素 b5 激活雄激素生物合成和药物代谢
- 批准号:
8438169 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
细胞色素 b5 激活雄激素生物合成和药物代谢
- 批准号:
9913550 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
细胞色素 b5 激活雄激素生物合成和药物代谢
- 批准号:
7939798 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
细胞色素 b5 激活雄激素生物合成和药物代谢
- 批准号:
8691516 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Steroidogenic Factor 1: Mediator of Gonadal Function
类固醇生成因子 1:性腺功能调节剂
- 批准号:
7350915 - 财政年份:2004
- 资助金额:
-- - 项目类别:
Fusion Proteins As Probes of P450 Structure and Function
融合蛋白作为 P450 结构和功能的探针
- 批准号:
6611899 - 财政年份:2003
- 资助金额:
-- - 项目类别:
Fusion Proteins As Probes of P450 Structure and Function
融合蛋白作为 P450 结构和功能的探针
- 批准号:
6731049 - 财政年份:2003
- 资助金额:
-- - 项目类别:
相似海外基金
The role of ZNRF3/Znrf3 exon2 deletion on zonation and maintenance of the adrenal cortex
ZNRF3/Znrf3 外显子 2 缺失对肾上腺皮质分区和维持的作用
- 批准号:
22K08680 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the role of proinsulin-positive bone marrow-derived cells appearing in the adrenal cortex
研究肾上腺皮质中出现的胰岛素原阳性骨髓来源细胞的作用
- 批准号:
21K07338 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
The contribution of capsular and subcapsular progenitor cells in homeostatic adrenal cortex self-renewal and zonal-specific remodelling.
被膜和被膜下祖细胞在稳态肾上腺皮质自我更新和区域特异性重塑中的贡献。
- 批准号:
BB/V007246/1 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Research Grant
Elucidating and modelling complex postnatal steroid hormone changes in preterm infants: insights into the developing immature neonatal adrenal cortex
阐明和模拟早产儿复杂的产后类固醇激素变化:深入了解发育中的未成熟新生儿肾上腺皮质
- 批准号:
MR/V037757/1 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Research Grant
Role of the BMP system and effect on blood pressure regulation in the adrenal cortex
BMP 系统的作用及其对肾上腺皮质血压调节的影响
- 批准号:
20K17512 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanism establishing sex difference in adrenal cortex cell proliferation by sex hormones
阐明性激素在肾上腺皮质细胞增殖中建立性别差异的机制
- 批准号:
20K08863 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of sexually dimorphic functions of adrenal cortex by sex chromosomes
性染色体对肾上腺皮质性二态性功能的调节
- 批准号:
20H03436 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying a role of delta-5 steroids from adrenal cortex for development of adrenal medulla
确定肾上腺皮质 delta-5 类固醇对肾上腺髓质发育的作用
- 批准号:
25860764 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Young Scientists (B)
The production mechanism and role of progesterone in female mouse adrenal cortex.
雌性小鼠肾上腺皮质孕酮的产生机制及其作用。
- 批准号:
22591015 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Regulation of Adrenal Cortex Homeostasis and Remodeling
肾上腺皮质稳态和重塑的分子调控
- 批准号:
8490361 - 财政年份:2009
- 资助金额:
-- - 项目类别: